A Novel Case of Reccurrent Hemarthrosis in a Patient with Undiagnosed Hemophilia
DOI:
10.29303/jbt.v25i4a.10941Published:
2025-12-31Downloads
Abstract
Hemophilia is an inherited X-linked recessive bleeding disorder characterized by deficiency of coagulation factors and commonly presents with hemarthrosis that may lead to permanent joint damage if diagnosis is delayed. This report aims to describe a case of recurrent hemarthrosis that led to the diagnosis of previously unrecognized hemophilia B. We report a 3-year-old boy with progressive swelling and pain of the left knee following minor trauma and surgical intervention, with a history of easy bruising and prolonged bleeding after circumcision. Laboratory evaluation showed prolonged activated partial thromboplastin time with normal prothrombin time and platelet count, and coagulation factor assay revealed factor IX activity of 1.2%, consistent with moderate hemophilia B. Recurrent hemarthrosis in this patient was the key clinical manifestation that prompted further diagnostic evaluation. This case highlights that recurrent or persistent joint bleeding in children, especially in the absence of a clear family history, should raise strong suspicion of hemophilia. Early recognition through careful bleeding history, coagulation screening, and specific factor assays is essential to prevent long-term musculoskeletal complications and unnecessary surgical procedures.
Keywords:
APTT Coagulation screening Factor IX Hemophilia B HemarthrosisReferences
Chowdary, P., Carcao, M., Kenet, G., & Pipe, S. W. (2025). Haemophilia. The Lancet, 405(10480), 736–750. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02139-1/abstract
Goodeve, A. C. (2015). Hemophilia B: Molecular pathogenesis and mutation analysis. Journal of Thrombosis and Haemostasis, 13(7), 1184–1195. https://doi.org/10.1111/jth.12958
Gooding, R., Thachil, J., Alamelu, J., Motwani, J., & Chowdary, P. (2021). Asymptomatic joint bleeding and joint health in hemophilia: A review of variables, methods, and biomarkers. Journal of Blood Medicine, 12, 209–220. https://doi.org/10.2147/JBM.S304597
Gualtierotti, R., Solimeno, L. P., & Peyvandi, F. (2021). Hemophilic arthropathy: Current knowledge and future perspectives. Journal of Thrombosis and Haemostasis, 19(9), 2112–2121. https://doi.org/10.1111/jth.15444
Jelbert, A., Vaidya, S., & Fotiadis, N. (2009). Imaging and staging of haemophilic arthropathy. Clinical Radiology, 64(11), 1119–1128. https://doi.org/10.1016/j.crad.2009.06.007
Kementerian Kesehatan Republik Indonesia. (2021). Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/243/2021 tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Hemofilia. Kementerian Kesehatan Republik Indonesia. https://jdih.kemkes.go.id
Khan, S., & Dickerman, J. D. (2024). Physiology, coagulation pathways. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482253/
Knobe, K., & Berntorp, E. (2011). Haemophilia and joint disease: Pathophysiology, evaluation, and management. Journal of Comorbidity, 1(1), 51–59. https://doi.org/10.15256/joc.2011.1.2
Kovač, K., Caktaš, I. L., Kalebota, N., & Perić, P. (2025). Hemophilic arthropathy—Pathophysiology and advances in treatment. Rheumato, 5(2), 5. https://doi.org/10.3390/rheumato5020005
Kurniawan, Y. (2024). Successful bypassing agent treatment in intracranial bleeding hemophilia A patient with high titer inhibitor: A case report. Jurnal Kedokteran Unram, 13(2). https://doi.org/10.29303/jku.v13i2.4409
Lee, H. J., Parikh, A., Ahuja, S., & Nayak, L. V. (2022). Preferential inheritance in hemophilia. Blood, 140(Supplement 1), 2747–2748. https://doi.org/10.1182/blood-2022-164700
Levy, B. J., Sperling, K., Davila, J., & Levy, I. M. (2020). A novel case of recurrent hemarthrosis following knee arthroscopy in a patient with undiagnosed hemophilia. Arthroscopy, Sports Medicine, and Rehabilitation, 2(3), e289–e294. https://doi.org/10.1016/j.asmr.2020.03.001
Mårtensson, A., Letelier, A., Manderstedt, E., Glosli, H., & Ljung, R. (2024). Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B. Haemophilia, 30(3), e1–e8. https://doi.org/10.1111/hae.15019
Melchiorre, D., Manetti, M., & Matucci-Cerinic, M. (2017). Pathophysiology of hemophilic arthropathy. Journal of Clinical Medicine, 6(7), 63. https://doi.org/10.3390/jcm6070063
Miesbach, W., von Drygalski, A., Smith, C., Sivamurthy, K., Pinachyan, K., Benson-Kennedy, D., Drelich, D., & Kulkarni, R. (2023). The current challenges faced by people with hemophilia B. European Journal of Haematology, 111(6), 789–799. https://doi.org/10.1111/ejh.14135
Miller, C. H. (2021). The clinical genetics of hemophilia B (factor IX deficiency). The Application of Clinical Genetics, 14, 445–454. https://doi.org/10.2147/TACG.S288256
Rachmawati, A., Suryadinata, H., & Nuraini, S. (2017). Pemeriksaan laboratorium pada hemofilia. Althea Medical Journal, 4(3), 424–430. https://journal.fk.unpad.ac.id/index.php/amj/article/view/946/891
Rodriguez-Merchan, E. C. (2012). Musculo-skeletal complications of hemophilia. Journal of Hematology. https://doi.org/10.4021/jh18e
Selim, C. (2025). Hemophilia B. In C. Th. S. Sibinga (Ed.), Coagulation disorders – Innovative developments in diagnostic and therapeutic approaches. IntechOpen. https://doi.org/10.5772/intechopen.1007363
Shen, G., Gao, M., Cao, Q., & Li, W. (2022). The molecular basis of FIX deficiency in hemophilia B. International Journal of Molecular Sciences, 23(5), 2762. https://doi.org/10.3390/ijms23052762
Srivastava, A., Santagostino, E., Dougall, A., Kitchen, S., Sutherland, M., Pipe, S. W., Carcao, M., Mahlangu, J., Ragni, M. V., Windyga, J., Llinás, A., Goddard, N. J., Mohan, R., Poonnoose, P. M., Feldman, B. M., Lewis, S. Z., Van den Berg, H. M., & Pierce, G. F. (2020). WFH guidelines for the management of hemophilia (3rd ed.). Haemophilia, 26(Suppl 6), 1–158. https://doi.org/10.1111/hae.14046
Tantawy, A. A. G. (2010). Coagulation profile and bleeding manifestations in children with hemophilia. The Egyptian Journal of Haematology, 35(2), 67–73. https://www.sciencedirect.com/science/article/pii/S1110863010000108
Thachil, J., Connors, J. M., Mahlangu, J., & Sholzberg, M. (2023). Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets. Journal of Thrombosis and Haemostasis, 21(7), 1737–1740. https://www.sciencedirect.com/science/article/pii/S1538783623002477
Valentino, L. A. (2010). Blood-induced joint disease: The pathophysiology of hemophilic arthropathy. Journal of Thrombosis and Haemostasis, 8(9), 1895–1902. https://doi.org/10.1111/j.1538-7836.2010.03962.x
License
Copyright (c) 2026 Nova Ramadhita, Yudhi Kurniawan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
